Ventria Bioscience Competitors and Similar CompaniesClear all
Travere Therapeutics's competitors and similar companies include Sosei Heptares.
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. | ||
Founding Date | Founding Date 2011 | Founding Date 1990 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ Dublin, IE | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB |
Employees | Employees 46293% increase | Employees 387 |
Valuation ($) | Valuation ($) 1.4 b | Valuation ($) 697 m |
Financial | ||
Revenue (est.) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) ¥29.6b (FY, 2025) |
Cost of goods | Cost of goods $10.3m (FY, 2025) | Cost of goods ¥7.3b (FY, 2025) |
Gross profit | Gross profit $480.4m (FY, 2025) | Gross profit ¥24b (FY, 2025) |
Net income | Net income ($25.5m) (FY, 2025) | Net income (¥12.5b) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 25m | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Sosei Heptares
HQ
Tokyo, JP
Employees
387
Sosei Heptares is a biopharmaceutical company that specializes in drug development.
View company